New eye injection aims to halt vision loss in dry AMD
Disease control
Recruiting now
This early-stage trial is testing a new drug called VOY-101 for people with advanced dry age-related macular degeneration (AMD) and geographic atrophy, a condition that causes blind spots. The drug is injected into the eye and aims to slow damage to the retina and preserve vision…
Phase: PHASE1, PHASE2 • Sponsor: Perceive Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC